Ignite Creation Date:
2024-05-05 @ 10:42 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01172223
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2010-07-28
Brief Title:
Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer
Sponsor:
Prof Dirk Elling
Organization:
Sana-Klinikum Lichtenberg
Organization Data
Organization:
Sana-Klinikum Lichtenberg
Class:
OTHER
Study ID:
LAPADO-Study
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Prof Dirk Elling
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Dirk Elling
Responsible Party Title:
Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Sana-Klinikum Lichtenberg
Old Name:
None
Old Organization:
None